Case Studies
Week In Review: Organigram Expands U.S. Market; The Senator Who Legalized Consumable Hemp Now Wants to Ban It; Curaleaf Takes Full Control of European Arm in Bold Strategic Move
LOS ANGELES — Welcome to the far too-exciting world of ...
Method Man and Zamnesia Partner to Launch Eight TICAL Cannabis Seeds in U.S. and Europe
LOS ANGELES- Zamnesia—a European online retailer specializing in cannabis seeds—has ...
Aurora Cannabis Denies Acquisition of MedLeaf Therapeutics
LOS ANGELES- Aurora Cannabis Inc. publicly refuted recent reports claiming ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Bipartisan Legislation Proposes Framework for Federal Cannabis Legalization
LOS ANGELES- In a significant move towards federal cannabis reform, a bipartisan group of U.S. lawmakers has reintroduced the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment (PREPARE) Act. The legislation aims to establish ...
Greewave Advisors Analysis: Cannabis Companies & Cash Flow – Size Matters
Over the past 6 years (2019-2024), the Tier 1 Multistate Operators (MSOs) have generated $2.3B in Cash Flow from Operations (CFO); Assuming all unpaid 280E related tax liabilities are satisfied this amount is $1.3 Billion. ...
New Mexico Takes a Landmark Step Toward Legal Psychedelic Therapy
LOS ANGELES- New Mexico just made history—again. Governor Michelle Lujan Grisham has officially signed the Medical Psilocybin Act into law, positioning New Mexico as the third U.S. state to legalize psilocybin for therapeutic use. But ...
4/20 Cannabis Price Wars: How a Cultural Milestone Became a Cautionary Tale
LOS ANGELES- Once a day to honor cannabis culture, April 20th—aka 4/20—has increasingly become a flashpoint in the cannabis industry’s struggle for survival. What began as a grassroots celebration has devolved, in many markets, into ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Braxia Scientific Corp. Announces Financial Results and Strategic Review
LOS ANGELES- Braxia Scientific Corp, a medical research company known for its innovative ketamine and psilocybin treatments for depression and related disorders, has recently disclosed its financial statements and management discussion for the first half ...
Germany’s Cannabis Legalization Vote Postponed Amid Political Hurdles and Public Debate
BERLIN- Germany's anticipated vote on legalizing cannabis, a significant step in the country's journey towards legalization, has been deferred to next year. This postponement, influenced by the Social Democratic Party (SPD)'s concerns, represents the latest ...
Branded Legacy, Inc. Acquires MariJPharmaceuticals to Bolster CBD Production and Intellectual Property
LOS ANGELES - In a notable expansion of its operations, Branded Legacy, Inc. announced on Tuesday the acquisition of Florida-based MariJ Pharmaceuticals, Inc., a company specializing in certified organic mobile extraction and production of CBD ...
Alabama Medical Cannabis Licensing: A Third Attempt Amid Challenge
LOS ANGELES -In a critical step toward establishing its medical cannabis industry, Alabama's Medical Cannabis Commission (AMCC) approved a new set of licenses on December 1, marking the third attempt in a complicated licensing journey. ...
5 Highlights From this Year’s MJBizCon 2023 in Las Vegas
LOS ANGELES- MJBizCon, the premier cannabis industry conference, made its mark in Las Vegas this year, captivating attendees with the latest trends, innovations, and groundbreaking developments. It's tough now for many operators with many going ...
Ohio Lawmaker Proposes Bill Challenging Newly Approved Cannabis Legalization
LOS ANGELES- A significant development has emerged in Ohio's cannabis legislation landscape. Republican State Representative Gary Click of Vickery has introduced House Bill 341, a legislative proposal aimed at revising the voter-approved measure that recently ...
Minnesota Man Offers Free Cannabis Cultivation Workshops to Public
LOS ANGELES- In a remarkable initiative supporting Minnesota's recent legalization of recreational cannabis, Steve Rosenfeldt, a local entrepreneur, is offering free workshops on cannabis cultivation and basics. Aimed at empowering residents with the skills and ...
Clearmind Medicine Announces Promising Results in Obesity Treatment from Pre-Clinical Trial
Clearmind Medicine Inc. a biotech company at the forefront of developing novel psychedelic-derived therapeutics, has announced encouraging outcomes from its latest pre-clinical trial. The study, spearheaded by Professor Joseph Tam of The Hebrew University of ...
Cybin Inc. Unveils Promising Phase 2 Results for Psychedelic Depression Treatment CYB003
Cybin Inc. a psychedelic biotech drug development, has recently announced the comprehensive results from its Phase 2 trial of CYB003, a groundbreaking treatment for Major Depressive Disorder (MDD). These findings, presented at a high-profile R&D ...
Venture West Secures $17.5 Million Refinance Loan for Cannabis Firm Cal Grow’s Headquarters
LOS ANGELES- In a significant move underscoring the growing financial robustness of the cannabis industry, Venture West Funding, a California commercial mortgage broker, has successfully arranged a $17.5 million refinance loan for Cal Grow, a ...
Oregon’s Cannabis Market Faces Oversupply Challenges Amid Regulatory Complexities
LOS ANGELES- Oregon, a state known for its progressive stance on cannabis, is currently grappling with significant oversupply issues in its market. This challenge is compounded by various other difficulties that have been persisting in ...
University of Utah Launches Medical Cannabis Research Center
LOS ANGELES- The University of Utah is taking a significant step forward in the realm of medical cannabis research with the establishment of the Center for Medical Cannabis Research (CMCR). Announced on November 21, this ...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results
LOS ANGELES- Numinus Wellness Inc. has announced its financial results for the fourth quarter and the full year of fiscal 2023, highlighting significant revenue growth and strategic advancements in its operations. Fourth Quarter Fiscal 2023 ...
New York Cannabis Control Board Approves Settlement
NEW YORK- In a pivotal decision this week, the New York Cannabis Control Board resolved a lawsuit brought by military veterans, unlocking the way for over 400 adult-use cannabis dispensaries to progress in the state. ...
California and Michigan Boost Social Equity in Cannabis Industry with New Funding Initiatives
LOS ANGELES- In a significant move to bolster social equity within the cannabis industry, both California and Michigan have recently taken steps to channel more funding into social equity cannabis companies. California is set to ...
Clearmind Medicine Inc Reports Promising Results in Pre-Clinical Trial for Combination Therapy
LOS ANGELES- Clearmind Medicine Inc has announced the results of its pre-clinical trial involving a combination therapy, marking a significant step in the development of treatments for addictions, obesity, metabolic disorders, and depression. The trial ...
RIV Capital’s Ambitious Transition to Adult-Use Cannabis Sales in New York
LOS ANGELES- RIV Capital, a Toronto-based cannabis investment firm, has navigated a turbulent path in its growth story, particularly in the New York market. Initially setting up as one of the few medical cannabis operators ...
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...
Record Sales on Green Wednesday Signal Booming Cannabis Market
LOS ANGELES- The cannabis industry experienced a significant surge in sales on Green Wednesday, the day before Thanksgiving, marking it as a high-point in annual cannabis commerce. Jane Technologies reported recreational cannabis sales totaling an ...
Arkansas and Rhode Island Cannabis Markets
LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...
Wisconsin Legislators Advocate for Veterans’ Access to Psilocybin Therapy Amid National Psychedelic Research Surge
LOS ANGELES- In a groundbreaking move, Wisconsin lawmakers are pushing for enhanced access to psilocybin, a psychedelic compound found in magic mushrooms, for military veterans suffering from post-traumatic stress disorder (PTSD). This bipartisan bill represents ...
Irwin Naturals Inc. Reports Financial Performance in Q3 2023
LOS ANGELES- Irwin Naturals Inc, a key player in the cannabis and mental health sectors, recently disclosed its financial results for the third quarter of fiscal 2023, ending September 30, 2023. The report presents a complex ...
Maryland Supreme Court Refuses to Review Injunction on Anti-Intoxicating Hemp Law
LOS ANGELES- The Maryland Supreme Court has recently opted not to review a lower court's injunction against the enforcement of the state's law aimed at banning intoxicating hemp products. This decision, as detailed in a ...
Georgia Advances Medical Cannabis Program After Legal Delays
LOS ANGELES' In a significant development for Georgia's medical cannabis sector, state regulators have resumed the licensing process, concluding a prolonged two-year legal standoff. This move, as reported by the Valdosta Daily Times, comes after ...
Algernon Pharmaceuticals Partners with Seyltx Inc.
LOS ANGELES- Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, has announced a significant advancement in its research program. The company has signed a Letter of Intent (LOI) with Seyltx Inc., a U.S.-based ...
